TF and colorectal carcinoma: A fixed-effects model meta-analysis revealed no statistically significant effect of ω-3 PUFA supplementation on TF levels in CRC patients [MD = −0.13, 95% CI (−0.31, 0.05), Z = 1.41, p = 0.16].